1. Home
  2. SWAG vs CLRB Comparison

SWAG vs CLRB Comparison

Compare SWAG & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stran & Company Inc.

SWAG

Stran & Company Inc.

HOLD

Current Price

$1.37

Market Cap

29.1M

ML Signal

HOLD

Logo Cellectar Biosciences Inc.

CLRB

Cellectar Biosciences Inc.

HOLD

Current Price

$1.43

Market Cap

24.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SWAG
CLRB
Founded
1994
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.1M
24.5M
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
SWAG
CLRB
Price
$1.37
$1.43
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $11.50
AVG Volume (30 Days)
18.6K
★ 76.5K
Earning Date
11-11-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 81.82
N/A
EPS
★ 0.06
N/A
Revenue
★ $116,191,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$23.17
★ N/A
Revenue Growth
★ 40.58
N/A
52 Week Low
$1.32
$1.34
52 Week High
$3.50
$5.07

Technical Indicators

Market Signals
Indicator
SWAG
CLRB
Relative Strength Index (RSI) 35.50 19.51
Support Level $1.32 N/A
Resistance Level $1.84 $3.03
Average True Range (ATR) 0.08 0.16
MACD 0.00 -0.04
Stochastic Oscillator 16.92 8.78

Price Performance

Historical Comparison
SWAG
CLRB

About SWAG Stran & Company Inc.

Stran & Co Inc is an outsourced marketing solutions provider, working closely with customers to develop sophisticated marketing programs that leverage promotional products and loyalty incentive expertise. In addition to selling branded products, it offers its clients custom sourcing capabilities, which is a flexible and customizable e-commerce solution for promoting branded merchandise and other promotional products, managing promotional loyalty and incentives, print collateral, event assets, order and inventory management, and designing and hosting online retail pop-up shops. The company's segment consists of the Stran segment and the SLS segment. The company generates the majority of its revenue from the Stran segment.

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. The products under development include Iopofosine, CLR 121125 ,CLR 121225 and others. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

Share on Social Networks: